Solution/solid-phase synthesis of partially modified retro- and retro-inverso-ψ[NHCH(CF3)]-peptidyl hydroxamates and their evaluation as MMP-9 inhibitors

Alessandro Volonterio, Stefano Bellosta, Pierfrancesco Bravo, Monica Canavesi, Eleonora Corradi, Stefano V. Meille, Mara Monetti, Nathalie Moussier, Matteo Zanda

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The synthesis of a novel family of partially modified (PM) retro-and retro-inverso-peptidyl hydroxamates, each incorporating a [CH(CF3)CH2CO] unit as a surrogate for the conventional malonyl group, has been accomplished both in solution and in solid phase. The key step is the Michael-type N-addition of free or polymer-bound α-amino hydroxamates to 3-[(E)-enoyl]-1,3-oxazolidin-2-ones, which takes place in high yields, although with low stereocontrol. This method is suitable for the preparation of combinatorial libraries of PM retro-ψNHCH(CF3)]-peptidyl hydroxamates for screening as metalloprotease inhibitors. A number of tri- and tetrapeptidyl hydroxamates were indeed obtained either in diastereomerically pure form by solution-phase synthesis followed by chromatographic purification, or as mixtures of two epimers by solid-phase synthesis and release from the resin. X-ray diffraction of a Tfm-retropeptidyl hydroxamate showed an interesting turn-like conformation with an intramolecularly hydrogen-bonded nine-membered ring, and a nearly planar geometry of the NH group bound to the CH(CF3) group. Three retro-peptidyl hydroxamates were submitted to bioassays, and displayed the capacity to reduce MMP-9 (Gelatinase B) gelatinolytic activity.

Original languageEnglish
Pages (from-to)428-438
Number of pages11
JournalEuropean Journal of Organic Chemistry
Issue number3
Publication statusPublished - 2002

Fingerprint

Matrix Metalloproteinases
inhibitors
solid phases
Solid solutions
evaluation
synthesis
methylidyne
Oxazolidinones
bioassay
Bioassay
Matrix Metalloproteinase 9
Metalloproteases
purification
resins
Purification
Conformations
Hydrogen
Screening
Polymers
screening

Keywords

  • Fluorine
  • Matrix metalloproteinases
  • Michael additions
  • Peptidomimetics
  • Solid-phase synthesis

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Solution/solid-phase synthesis of partially modified retro- and retro-inverso-ψ[NHCH(CF3)]-peptidyl hydroxamates and their evaluation as MMP-9 inhibitors. / Volonterio, Alessandro; Bellosta, Stefano; Bravo, Pierfrancesco; Canavesi, Monica; Corradi, Eleonora; Meille, Stefano V.; Monetti, Mara; Moussier, Nathalie; Zanda, Matteo.

In: European Journal of Organic Chemistry, No. 3, 2002, p. 428-438.

Research output: Contribution to journalArticle

Volonterio, Alessandro ; Bellosta, Stefano ; Bravo, Pierfrancesco ; Canavesi, Monica ; Corradi, Eleonora ; Meille, Stefano V. ; Monetti, Mara ; Moussier, Nathalie ; Zanda, Matteo. / Solution/solid-phase synthesis of partially modified retro- and retro-inverso-ψ[NHCH(CF3)]-peptidyl hydroxamates and their evaluation as MMP-9 inhibitors. In: European Journal of Organic Chemistry. 2002 ; No. 3. pp. 428-438.
@article{109d824de7cd4632bb00ff873aed50af,
title = "Solution/solid-phase synthesis of partially modified retro- and retro-inverso-ψ[NHCH(CF3)]-peptidyl hydroxamates and their evaluation as MMP-9 inhibitors",
abstract = "The synthesis of a novel family of partially modified (PM) retro-and retro-inverso-peptidyl hydroxamates, each incorporating a [CH(CF3)CH2CO] unit as a surrogate for the conventional malonyl group, has been accomplished both in solution and in solid phase. The key step is the Michael-type N-addition of free or polymer-bound α-amino hydroxamates to 3-[(E)-enoyl]-1,3-oxazolidin-2-ones, which takes place in high yields, although with low stereocontrol. This method is suitable for the preparation of combinatorial libraries of PM retro-ψNHCH(CF3)]-peptidyl hydroxamates for screening as metalloprotease inhibitors. A number of tri- and tetrapeptidyl hydroxamates were indeed obtained either in diastereomerically pure form by solution-phase synthesis followed by chromatographic purification, or as mixtures of two epimers by solid-phase synthesis and release from the resin. X-ray diffraction of a Tfm-retropeptidyl hydroxamate showed an interesting turn-like conformation with an intramolecularly hydrogen-bonded nine-membered ring, and a nearly planar geometry of the NH group bound to the CH(CF3) group. Three retro-peptidyl hydroxamates were submitted to bioassays, and displayed the capacity to reduce MMP-9 (Gelatinase B) gelatinolytic activity.",
keywords = "Fluorine, Matrix metalloproteinases, Michael additions, Peptidomimetics, Solid-phase synthesis",
author = "Alessandro Volonterio and Stefano Bellosta and Pierfrancesco Bravo and Monica Canavesi and Eleonora Corradi and Meille, {Stefano V.} and Mara Monetti and Nathalie Moussier and Matteo Zanda",
year = "2002",
language = "English",
pages = "428--438",
journal = "Annalen der Pharmacie",
issn = "0075-4617",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Solution/solid-phase synthesis of partially modified retro- and retro-inverso-ψ[NHCH(CF3)]-peptidyl hydroxamates and their evaluation as MMP-9 inhibitors

AU - Volonterio, Alessandro

AU - Bellosta, Stefano

AU - Bravo, Pierfrancesco

AU - Canavesi, Monica

AU - Corradi, Eleonora

AU - Meille, Stefano V.

AU - Monetti, Mara

AU - Moussier, Nathalie

AU - Zanda, Matteo

PY - 2002

Y1 - 2002

N2 - The synthesis of a novel family of partially modified (PM) retro-and retro-inverso-peptidyl hydroxamates, each incorporating a [CH(CF3)CH2CO] unit as a surrogate for the conventional malonyl group, has been accomplished both in solution and in solid phase. The key step is the Michael-type N-addition of free or polymer-bound α-amino hydroxamates to 3-[(E)-enoyl]-1,3-oxazolidin-2-ones, which takes place in high yields, although with low stereocontrol. This method is suitable for the preparation of combinatorial libraries of PM retro-ψNHCH(CF3)]-peptidyl hydroxamates for screening as metalloprotease inhibitors. A number of tri- and tetrapeptidyl hydroxamates were indeed obtained either in diastereomerically pure form by solution-phase synthesis followed by chromatographic purification, or as mixtures of two epimers by solid-phase synthesis and release from the resin. X-ray diffraction of a Tfm-retropeptidyl hydroxamate showed an interesting turn-like conformation with an intramolecularly hydrogen-bonded nine-membered ring, and a nearly planar geometry of the NH group bound to the CH(CF3) group. Three retro-peptidyl hydroxamates were submitted to bioassays, and displayed the capacity to reduce MMP-9 (Gelatinase B) gelatinolytic activity.

AB - The synthesis of a novel family of partially modified (PM) retro-and retro-inverso-peptidyl hydroxamates, each incorporating a [CH(CF3)CH2CO] unit as a surrogate for the conventional malonyl group, has been accomplished both in solution and in solid phase. The key step is the Michael-type N-addition of free or polymer-bound α-amino hydroxamates to 3-[(E)-enoyl]-1,3-oxazolidin-2-ones, which takes place in high yields, although with low stereocontrol. This method is suitable for the preparation of combinatorial libraries of PM retro-ψNHCH(CF3)]-peptidyl hydroxamates for screening as metalloprotease inhibitors. A number of tri- and tetrapeptidyl hydroxamates were indeed obtained either in diastereomerically pure form by solution-phase synthesis followed by chromatographic purification, or as mixtures of two epimers by solid-phase synthesis and release from the resin. X-ray diffraction of a Tfm-retropeptidyl hydroxamate showed an interesting turn-like conformation with an intramolecularly hydrogen-bonded nine-membered ring, and a nearly planar geometry of the NH group bound to the CH(CF3) group. Three retro-peptidyl hydroxamates were submitted to bioassays, and displayed the capacity to reduce MMP-9 (Gelatinase B) gelatinolytic activity.

KW - Fluorine

KW - Matrix metalloproteinases

KW - Michael additions

KW - Peptidomimetics

KW - Solid-phase synthesis

UR - http://www.scopus.com/inward/record.url?scp=0036172915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036172915&partnerID=8YFLogxK

M3 - Article

SP - 428

EP - 438

JO - Annalen der Pharmacie

JF - Annalen der Pharmacie

SN - 0075-4617

IS - 3

ER -